Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Treasury Shares: 2021-2025

Historic Treasury Shares for Biofrontera (BFRI) over the last 4 years, with Sep 2025 value amounting to $412,500.

  • Biofrontera's Treasury Shares fell 8.33% to $412,500 in Q3 2025 from the same period last year, while for Sep 2025 it was $412,500, marking a year-over-year decrease of 8.33%. This contributed to the annual value of $450,000 for FY2024, which is 9331.98% up from last year.
  • As of Q3 2025, Biofrontera's Treasury Shares stood at $412,500, which was down 8.33% from $450,000 recorded in Q2 2025.
  • Biofrontera's 5-year Treasury Shares high stood at $343.5 million for Q2 2022, and its period low was $4,771 during Q2 2023.
  • Over the past 3 years, Biofrontera's median Treasury Shares value was $378,006 (recorded in 2023), while the average stood at $257,510.
  • Per our database at Business Quant, Biofrontera's Treasury Shares slumped by 100.00% in 2023 and then spiked by 9,331.98% in 2024.
  • Biofrontera's Treasury Shares (Quarterly) stood at $8,504 in 2021, then skyrocketed by 101.98% to $17,176 in 2022, then crashed by 72.22% to $4,771 in 2023, then surged by 9,331.98% to $450,000 in 2024, then decreased by 8.33% to $412,500 in 2025.
  • Its Treasury Shares stands at $412,500 for Q3 2025, versus $450,000 for Q2 2025 and $450,000 for Q1 2025.